Yehudah Buchweitz is a distinguished litigator at Weil Gotshal and Manges, with a strong focus on complex commercial litigation and arbitration. He obtained his Doctor of Law degree from Fordham University School of Law and graduated with a Bachelor's degree in Politics, History, Legal Studies from Brandeis University. Buchweitz has been recognized by Chambers, Legal 500, Benchmark Litigation, and Law360 for his expertise in the field. He has obtained remarkable victories in crucial trials resulting in written decisions, including a significant win involving plaintiff-side competitor antitrust lawsuit regarding the market for epinephrine. Buchweitz has also been regarded as a leader in the life sciences industry, being named a Future Star by Benchmark Litigation and a Life Sciences Star for non-IP litigation and enforcement by LMG Life Sciences. He has an excellent record representing clients in federal civil rights cases regarding the establishment of an eruv and in RLUIPA actions. With a passion for what he does, Buchweitz actively works on pro bono cases as well. This material may be regarded as attorney advertising in some jurisdictions.